Lubrizol to Highlight Expansion of Medical Device Manufacturing Capabilities in India at World Health Expo, Dubai
As part of its global expansion, Lubrizol is introducing new contract manufacturing capabilities in India, including a state-of-the-art medical manufacturing site in Chennai, Tamil Nadu, scheduled to open mid-2026.
This new facility in Chennai, Tamil Nadu, will produce high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other devices for minimally invasive procedures. Leveraging Lubrizol’s advanced medical-grade thermoplastic polyurethane (TPU) and other biocompatible engineered polymers, the tubing produced is intended for minimally invasive device technologies, supporting applications in electrostimulation, cardiovascular, neurovascular, and beyond. Key capabilities include single and multi-lumen precision extrusion of TPU, Nylon, Pebax® and other engineered thermoplastics, tri layer tubing, balloon tubing, as well as braiding.
“We are strengthening our presence in India with strategic investments in local manufacturing, R&D, and technical capabilities,” said Mittal Shah, Business Head at Lubrizol. “These investments address our customers’ need for biocompatible, high-performance materials and advanced solutions that enable medical device innovation in India and globally.”
Visit Booth #S13.B112 at WHX Dubai to learn more about how Lubrizol can help you design, develop, and deliver next-generation medical devices. Contact us to discuss: Medical@Lubrizol.com.
About Us: Lubrizol combines advanced polymers, collaborative design, and best-in-class contract manufacturing to help customers deliver transformative medical technologies with confidence. From concept to commercialization, Lubrizol ensures quality, compliance, and excellence at every stage.
To learn more about Lubrizol’s medical-grade materials and device capabilities, visit https://www.lubrizol.com or connect with Lubrizol experts at the WHX Expo.
About The Lubrizol Corporation
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with more than 100 manufacturing facilities, sales and technical offices and more than 7,000 employees around the world. For more information, visit www.Lubrizol.com.
About Lubrizol in IMEA
Lubrizol IMEA, identified as one of Lubrizol’s high-growth geographies, serves the dynamic markets in India, the Middle East, and Africa with advanced solutions in additives, engineered materials and coatings and life sciences. The region comprises of four corporate offices including a global capabilities center and five manufacturing facilities in Maharashtra, Gujarat and Tamil Nadu. With a strong local-for-local strategy, we combine technical expertise and regional insights to drive innovation across sectors catering to the regional market needs through strategic investments and partnerships.
